Behçet's disease in children, an overview.

Area of Science:

• Rheumatology
• Pediatric Rheumatology
• Systemic Inflammatory Diseases

Background:

• Behçet's disease (BD) is a systemic inflammatory condition.
• Pediatric onset is rare, with significant genetic links.
• Early diagnosis is challenging due to overlapping symptoms with other inflammatory disorders.

Purpose of the Study:

• To introduce new international expert consensus classification criteria for pediatric BD.
• To highlight the heterogeneous clinical spectrum and prognostic factors in pediatric BD.
• To discuss current treatment strategies, emphasizing TNFα inhibitors for severe manifestations.

Main Methods:

• International expert consensus development.
• Review of clinical spectrum, genetic factors, and treatment outcomes in pediatric BD.
• Analysis of prognostic indicators, including gender, ethnicity, and geographic factors.

Main Results:

• New classification criteria for pediatric BD have been established.
• Young males with pediatric BD face a worse prognosis, with increased neurological, ocular, and vascular complications.
• TNFα inhibitors are effective for severe ocular, neurological, and gastrointestinal involvement.

Conclusions:

• The new criteria aim to improve early recognition of pediatric BD.
• Understanding the heterogeneous nature and risk factors is crucial for managing pediatric BD.
• Targeted therapies like TNFα inhibitors are vital for severe cases of pediatric BD.